Mirum Pharmaceuticals, Inc. (MIRM) insider trading

By person

13 insiders · 68 transactions

69.3×

Christopher Peetz holds 69.3 times base salary in stock. $52.35M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Peetz last reported holding, valued at $90.00, the price Common Stock was last bought or sold at on the open market here, on 4 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Christopher Peetz

Chief Executive Officer

—

$18.09M (20) scheduled

−$18.09M

581,637

0.8958%

$52.35M

+11.2%

Michael G Grey

Director

—

$11.10M (3) scheduled

−$11.10M

0.0000%

$0.00

—

Patrick J Heron

Director

$9.00M (1)

—

+$9.00M

464,713

0.7157%

$41.82M

+187.0%

Jolanda Howe

SVP, Global Controller

—

$5.55M (9) scheduled

−$5.55M

16,728

0.0258%

$1.51M

+589.5%

Eric Bjerkholt

Chief Financial Officer

—

$3.56M (12)

−$3.56M

44,745

0.0689%

$4.03M

+33.4%

Peter Radovich

President and COO

—

$2.32M (4)

−$2.32M

57,260

0.0882%

$5.15M

+95.9%

Saira Ramasastry

Director

—

$1.92M (9) scheduled

−$1.92M

0.0000%

$0.00

—

Joanne Quan

Chief Medical Officer

—

$1.46M (3)

−$1.46M

18,864

0.0291%

$1.70M

+28,055%

Laura Brege

Director

—

15,703

0.0242%

$1.41M

+57.0%

Laurent Fischer

Director

—

10,727

0.0165%

$965.43K

+58.9%

Timothy P Walbert

Director

—

9,680

0.0149%

$871.20K

—

Lon Cardon

Director

—

9,680

0.0149%

$871.20K

—

William Fairey

Director

—

2,500

0.0039%

$225.00K

—

Mirum Pharmaceuticals, Inc.

What the insiders did Net selling

By person